DNA was extracted from the tumor tissue ; mutation screening in the PIK@CA gene ( exons @ and @ ) and the KRAS gene ( exons @ and @ ) was first carried out using Sanger direct sequencing , and then completed by next-generation sequencing for PIK@CA .